Erica Jordan serves as Executive at Revance Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Erica Jordan has executed 1 insider transactions totaling $9.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 16, 2024 involved selling 2,392 shares valued at $9.1K.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 16, 2024 | RVNC | $9.1K | Sale | 2,392 | $3.80 | Discretionary |
Erica Jordan currently holds 114,864 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Erica Jordan has been a net seller of RVNC stock. They have purchased $0 and sold $9.1K worth of shares.
Erica Jordan's most recent insider trade was on Apr 16, 2024, when they sold 2,392 shares at $3.80 per share.
Get notified when new Form 4 filings are submitted